ASTM International - ASTM D8587-24
Standard Guide for Determining a Point of Departure (POD) or Assigning a Threshold of Toxicological Concern (TTC), if needed, for Use in a Toxicological Risk Assessment of a Non-Cannabinoid Ingredient Intended for Use in Cannabinoid Products for Vaporization
| Organization: | ASTM International |
| Publication Date: | 15 September 2024 |
| Status: | inactive |
| Page Count: | 10 |
| ICS Code (Tobacco, tobacco products and related equipment): | 65.160 |
significance And Use:
4.1 Significance:
4.1.1 This guide establishes an approach for conducting a toxicological risk-based assessment of non-cannabinoid ingredients designed to reduce the potential health risks... View More
scope:
1.1 This guide is not meant to classify the non-cannabinoid ingredient or final product as safe for inhalation. Inhaling anything other than clean air poses an inherent human health risk.
1.2 This guide shall cover all formulated (manufactured) cannabinoid-containi
1.3 This guide shall cover all formulated (manufactured) cannabinoid-containi
1.4 This guide shall cover all formulated (manufactured) cannabinoid-containi
1.5 This guide shall cover all non-cannabinoid ingredients, regardless of the method of obtention (source), used in formulated (manufactured) cannabinoid-containi
1.5.1 Because naturally-derived and synthetic compounds produce comparable biological effects, so long as their chemical structure and spatial orientation are identical, the method of obtention (source) of the compound is irrelevant to the need to conduct a toxicological risk assessment of the non-cannabinoid ingredients.
1.6 This guide includes considerations for thermal breakdown products of the non-cannabinoid ingredient through the process of aerosolization via vaporization device usage.
1.7 This guide excludes formulated (manufactured) cannabinoid-containi
1.8 This guide excludes the cannabinoids themselves.
1.8.1 Exclusion does not mean risk assessment of cannabinoids is unnecessary or that they are risk-free, only that they are beyond the scope of this standard. Investigation into these areas is encouraged to expand knowledge and safety of cannabinoid-containi
1.9 This guide excludes impurities and contaminants within the non-cannabinoid ingredients that are otherwise regulated. It is the responsibility of the user of this standard to know the impurities and contaminants and action limits set by the AHJ.
1.10 This guide excludes interactions between the compounds in the cannabinoid-containi
1.10.1 Exclusion does not mean risk assessment of interactions between compounds in the cannabinoid-containi
1.11 This standard does not purport to address all of the safety concerns, if any, associated with its use. It is the responsibility of the user of this standard to establish appropriate safety, health, and environmental practices and determine the applicability of regulatory limitations prior to use.
1.12 This international standard was developed in accordance with internationally recognized principles on standardization established in the Decision on Principles for the Development of International Standards, Guides and Recommendations issued by the World Trade Organization Technical Barriers to Trade (TBT) Committee.
Document History